Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.

about

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q46061403

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Endothelial dysfunction is ass ...... systemic lupus erythematosus.

@en

Endothelial dysfunction is ass ...... systemic lupus erythematosus.

@nl

type

Item

label

Endothelial dysfunction is ass ...... systemic lupus erythematosus.

@en

Endothelial dysfunction is ass ...... systemic lupus erythematosus.

@nl

prefLabel

Endothelial dysfunction is ass ...... systemic lupus erythematosus.

@en

Endothelial dysfunction is ass ...... systemic lupus erythematosus.

@nl

P1476

Endothelial dysfunction is ass ...... h systemic lupus erythematosus

@en

P2093

Anders A Bengtsson

http://www.w3.org/2001/XMLSchema#string

Andreas Jönsen

http://www.w3.org/2001/XMLSchema#string

Birgitta Gullstrand

http://www.w3.org/2001/XMLSchema#string

Christoffer Tandrup Nielsen

http://www.w3.org/2001/XMLSchema#string

Helena Tydén

http://www.w3.org/2001/XMLSchema#string

Niels H H Heegaard

http://www.w3.org/2001/XMLSchema#string

Robin Kahn

http://www.w3.org/2001/XMLSchema#string

P2860

The 1982 revised criteria for the classification of systemic lupus erythematosus

The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.

Assessment and treatment of endothelial dysfunction in humans.

Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness.

Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.

Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.

The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.

P304

e000508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/RMDOPEN-2017-000508

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christian Lood

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29119007

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

5663269

http://www.w3.org/2001/XMLSchema#string